Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Recursion Pharmaceuticals Inc Cl A (NQ: RXRX )

9.420 UNCHANGED
Streaming Delayed Price Updated: 4:15 PM EDT, May 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,108
Open 9.420
Bid (Size) 9.350 (1)
Ask (Size) 9.580 (29)
Prev. Close 9.420
Today's Range 9.420 - 9.420
52wk Range 4.970 - 16.75
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What's the Difference Between Biotech Stocks and TechBio Stocks?
A few enterprising businesses are marketing themselves differently. 
Via The Motley Fool
Recursion Pharm Stock Sees Relative Strength Rating Rise To 84
On Tuesday, Recursion Pharm stock had its Relative Strength (RS) Rating upgraded to 84, up from 78 a day earlier. 
Via Investor's Business Daily

Performance

YTD
-4.56%
-4.56%
1 Month
+28.16%
+28.16%
3 Month
-25.18%
-25.18%
6 Month
+37.32%
+37.32%
1 Year
+16.01%
+16.01%

More News

Read More
Sony Group Posts Upbeat Earnings, Joins GameStop, Paysafe And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
The Next Drug You Take May be Designed By A.I.
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Demystifying Recursion Pharmaceuticals: Insights From 4 Analyst Reviews
Via Benzinga
(RXRX) - Analyzing Recursion Pharmaceuticals's Short Interest
Via Benzinga
Recursion Pharmaceuticals Stock Surges 10% As Nvidia-Powered Supercomputer Completion Sparks Investor Optimism
Via Benzinga
Largest Clinical-Stage BioTech Drug Stocks Declined 3% Last Week
Via Talk Markets
Why Akoustis Technologies Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
GameStop, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday
Via Benzinga
Recursion Announces Completion of NVIDIA-Powered BioHive-2, the Largest Supercomputer in Pharmaceutical Industry
From Recursion Pharmaceuticals
Via GlobeNewswire
Cathie Wood Is Buying This Under-the-Radar AI Stock
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
RXRX Stock Earnings: Recursion Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Nvidia-Backed Recursion Pharmaceuticals Stock Is Up On Q1 Earnings: Everything You Need To Know
Via Benzinga
Nvidia Favorite SoundHound AI Delivers Beat-And-Raise Report
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
Recursion Provides Business Updates and Reports First Quarter 2024 Financial Results
From Recursion Pharmaceuticals
Via GlobeNewswire
Clinical-Stage BioTech Drug Stocks Portfolio Jumped 7% In First Week Of May
Via Talk Markets
Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9
From Recursion Pharmaceuticals
Via GlobeNewswire
Recursion to Participate in Upcoming Investor Conferences
From Recursion Pharmaceuticals
Via GlobeNewswire
Altitude Lab Secures Small Business Administration Growth Fund Accelerator Grant to Launch Horizon, a Commercialization Partnering Program
From Recursion Pharmaceuticals
Via GlobeNewswire
Nvidia Owns a 3.4% Stake in This Innovative Artificial Intelligence (AI) Stock Cathie Wood Loves
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
The Top 3 Biotech Stocks to Buy in April 2024
Via InvestorPlace
3 Millionaire-Maker Biotech Stocks
Via The Motley Fool
Jim Cramer Says This Energy Stock Is 'Terrific,' Calls Casey's General Stores A 'Winner'
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.